MolecularWare Lands $2.5M in Funding | GenomeWeb

NEW YORK, August 1 – The bioinformatics company MolecularWare has received $2.5 million in first-round funding, the company announced Wednesday.

The Cambridge, Mass.-based company said it would use the money to continue to commercialize its DigitalGenome suite of high throughput analysis software. 

The “Series A” funding came from several sources including lead investors Aspen Investment Group and KnowledgeCube Group. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."